3 Reasons to Avoid MMI and 1 Stock to Buy Instead

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.

MMI Cover Image

Marcus & Millichap trades at $29.92 and has moved in lockstep with the market. Its shares have returned 11.5% over the last six months while the S&P 500 has gained 7.9%.

Is now the time to buy Marcus & Millichap, or should you be careful about including it in your portfolio? Dive into our full research report to see our analyst team’s opinion, it’s free.

Why Do We Think Marcus & Millichap Will Underperform?

We’re sitting this one out for now. Here are three reasons why MMI doesn’t excite us, plus one stock we’d rather own.

1. Long-Term Revenue Growth Disappoints

A company’s long-term sales performance is one signal of its overall quality. Any business can experience short-term success, but top-performing ones enjoy sustained growth for years. Over the last five years, Marcus & Millichap grew its sales at a weak 1.9% compounded annual growth rate. This fell short of our benchmarks.

Marcus & Millichap Quarterly Revenue

2. Mediocre Free Cash Flow Margin Limits Reinvestment Potential

Free cash flow isn’t a prominently featured metric in company financials and earnings releases, but we think it’s telling because it accounts for all operating and capital expenses, making it tough to manipulate. Cash is king.

Marcus & Millichap has shown poor cash profitability relative to peers over the last two years, giving the company fewer opportunities to return capital to shareholders. Its free cash flow margin averaged 6.4%, below what we’d expect for a consumer discretionary business.

Marcus & Millichap Trailing 12-Month Free Cash Flow Margin

3. New Investments Fail to Bear Fruit as ROIC Declines

ROIC, or return on invested capital, is a metric showing how much operating profit a company generates relative to the money it has raised (debt and equity).

Unfortunately, Marcus & Millichap’s ROIC has decreased significantly over the last few years. Paired with its already low returns, these declines suggest its profitable growth opportunities are few and far between.

Marcus & Millichap Trailing 12-Month Return On Invested Capital

Final Judgment

We cheer for all companies serving everyday consumers, but in the case of Marcus & Millichap, we’ll be cheering from the sidelines. That said, the stock currently trades at 70.4× forward P/E (or $29.92 per share). This valuation tells us it’s a bit of a market darling with a lot of good news priced in - we think there are better opportunities elsewhere. We’d suggest looking at one of our all-time favorite software stocks.

Stocks We Would Buy Instead of Marcus & Millichap

ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren’t just high-quality businesses. Something is happening with them right now. Elite fundamentals meet near-term momentum — both boxes checked at the same time.

Find out which stocks our AI platform is flagging this week. See this week’s Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,460% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,552% between June 2020 and June 2025). Find your next big winner with StockStory today.

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.17
-0.49 (-0.21%)
AAPL  332.64
+10.98 (3.41%)
AMD  534.55
-5.14 (-0.95%)
BAC  61.99
+0.71 (1.16%)
GOOG  319.83
+1.49 (0.47%)
META  602.91
-3.19 (-0.53%)
MSFT  384.14
+2.56 (0.67%)
NVDA  210.12
+1.36 (0.65%)
ORCL  118.51
-1.53 (-1.27%)
TSLA  309.03
-10.66 (-3.33%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.